Literature DB >> 9232500

The natural history of great toe amputations.

D P Murdoch1, D G Armstrong, J B Dacus, T J Laughlin, C B Morgan, L A Lavery.   

Abstract

The purpose of this study is to report the prevalence of reamputation following resection of the great toe and first ray in adults with diabetes. We abstracted the medical records of 90 diabetic great-toe and first-ray amputees admitted between 1981 and 1991. The most common etiologies of initial amputations were ulcer with soft tissue infection (39%), ulcer with osteomyelitis (32%), and puncture wounds (12%). Sixty percent of all patients had a second amputation, 21% had a third, and 7% had a fourth. Fifteen percent of the patients who had a second amputation had it contralaterally. Seventeen percent subsequently underwent a below-knee amputation and 11% had a Transmetatarsal amputation on the same extremity, 3% had a below-knee amputation, and 2% a transmetatarsal amputation contralaterally. The mean time from the first to the second amputation was approximately 10 months. The results of this study suggest that a large proportion of patients undergoing an amputation at the level of the great toe or first ray have subsequent amputations in the first year following the initial procedure. Additionally, it appears that the contralateral foot may be at significant risk for distal amputation following resection of the hallux or first day.

Entities:  

Mesh:

Year:  1997        PMID: 9232500     DOI: 10.1016/s1067-2516(97)80116-0

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  13 in total

Review 1.  Updates on Diabetic Foot and Charcot Osteopathic Arthropathy.

Authors:  Brian M Schmidt; Crystal M Holmes
Journal:  Curr Diab Rep       Date:  2018-08-15       Impact factor: 4.810

2.  A study of surgical management of diabetic limb complications among rural population.

Authors:  M Madan; T K Naveen; M Balachandra
Journal:  Indian J Surg       Date:  2012-01-10       Impact factor: 0.656

Review 3.  Management of osteomyelitis of the foot in diabetes mellitus.

Authors:  Fran Game
Journal:  Nat Rev Endocrinol       Date:  2010-01       Impact factor: 43.330

4.  Validation of an algorithm to predict reulceration in amputation patients with diabetes.

Authors:  Raúl J Molines-Barroso; José L Lázaro-Martínez; Francisco J Álvaro-Afonso; Irene Sanz-Corbalán; José L García-Klepzig; Javier Aragón-Sánchez
Journal:  Int Wound J       Date:  2016-08-09       Impact factor: 3.315

5.  [Minor amputations for diabetic foot syndrome].

Authors:  G Rümenapf; W Lang; S Morbach
Journal:  Orthopade       Date:  2009-12       Impact factor: 1.087

6.  What are the most effective interventions in preventing diabetic foot ulcers?

Authors:  Lawrence A Lavery; Edgar J G Peters; David G Armstrong
Journal:  Int Wound J       Date:  2008-06       Impact factor: 3.315

7.  Re-amputation occurrence in the diabetic population in South Wales, UK.

Authors:  Rajani Kanade; Robert van Deursen; Jo Burton; Vanessa Davies; Keith Harding; Patricia Price
Journal:  Int Wound J       Date:  2007-10-24       Impact factor: 3.315

Review 8.  Neuropathic osteoarthropathy with and without superimposed osteomyelitis in patients with a diabetic foot.

Authors:  Antonio Leone; Victor N Cassar-Pullicino; Alessia Semprini; Laura Tonetti; Nicola Magarelli; Cesare Colosimo
Journal:  Skeletal Radiol       Date:  2016-02-17       Impact factor: 2.199

9.  Outcomes of surgical treatment of diabetic foot osteomyelitis: a series of 185 patients with histopathological confirmation of bone involvement.

Authors:  F J Aragón-Sánchez; J J Cabrera-Galván; Y Quintana-Marrero; M J Hernández-Herrero; J L Lázaro-Martínez; E García-Morales; J V Beneit-Montesinos; D G Armstrong
Journal:  Diabetologia       Date:  2008-08-22       Impact factor: 10.122

Review 10.  Lower extremity reamputation in people with diabetes: a systematic review and meta-analysis.

Authors:  Rongqi Liu; Brian J Petersen; Gary M Rothenberg; David G Armstrong
Journal:  BMJ Open Diabetes Res Care       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.